E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium
Hisani N. Horne, Hannah Oh, Mark E. Sherman, Maya Palakal, Stephen M. Hewitt, Marjanka K. Schmidt, Roger L. Milne, David Hardisson, Javier Benitez, Carl Blomqvist, Manjeet K. Bolla, Hermann Brenner, Jenny Chang-Claude, Renata Cora, Fergus J. Couch, Katarina Cuk, Peter Devilee, Douglas F. Easton, Diana M. Eccles, Ursula EilberJaana M. Hartikainen, Päivi Heikkilä, Bernd Holleczek, Maartje J. Hooning, Michael Jones, Renske Keeman, Arto Mannermaa, John W.M. Martens, Taru A. Muranen, Heli Nevanlinna, Janet E. Olson, Nick Orr, Jose I.A. Perez, Paul D.P. Pharoah, Kathryn J. Ruddy, Kai Uwe Saum, Minouk J. Schoemaker, Caroline Seynaeve, Reijo Sironen, Vincent T.H.B.M. Smit, Anthony J. Swerdlow, Maria Tengström, Abigail S. Thomas, A. Mieke Timmermans, Rob A.E.M. Tollenaar, Melissa A. Troester, Christi J. Van Asperen, Carolien H.M. Van Deurzen, Flora F. Van Leeuwen, Laura J. Van'T Veer, Montserrat García-Closas, Jonine D. Figueroa
Dive into the research topics of 'E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium'. Together they form a unique fingerprint.